Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
IQBAL J HUSSAIN Insider Profile
4 Followers
IQBAL J HUSSAIN, GC at Centessa Pharmaceuticals, holds 210.51K shares in Centessa Pharmaceuticals (Ticker: CNTA).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-66.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of IQBAL J HUSSAIN's holdings
Insider Roles
GC
Roles that IQBAL J HUSSAIN holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Oct 04, 2022 - Oct 04, 2023
Return:-47.70%
The most profitable trade made by IQBAL J HUSSAIN
IQBAL J HUSSAIN's Trading History
List of latest transactions for each holding click on a transaction to see IQBAL J HUSSAIN's performance on stock
You May Also Like
IQBAL J HUSSAIN insider profile FAQ
What is the percentage of profitable transactions made by IQBAL J HUSSAIN?
The percentage of profitable transactions made by IQBAL J HUSSAIN is 0%.
What is the average return per transaction made by IQBAL J HUSSAIN?
The average return per transaction made by IQBAL J HUSSAIN is -66.70%.
What stocks does IQBAL J HUSSAIN hold?
IQBAL J HUSSAIN holds: CNTA stocks.
What was IQBAL J HUSSAIN’s latest transaction?
IQBAL J HUSSAIN latest transaction was an Uninformative Sell of $67.91K.
What was IQBAL J HUSSAIN's most profitable transaction?
IQBAL J HUSSAIN’s most profitable transaction was an Informative Sell of CNTA stock on October 4, 2022. The return on the trade was -47.70%.
What is IQBAL J HUSSAIN's role in Centessa Pharmaceuticals?
IQBAL J HUSSAIN's role in Centessa Pharmaceuticals is GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.